Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous
thromboembolism, arterial thrombosis, and obstetric morbidities in the setting of persistently …

Recurrent thrombosis and miscarriages are the main clinical manifestations of
antiphospholipid syndrome (APS). Although most patients display both clinical signs, some …

Background Despite expansion in the 2006 Sydney antiphospholipid syndrome (APS)
classification criteria to include IgG/IgM anti-β2-glycoprotein (aβ2GPI) antibodies in addition …

Thrombotic manifestations of antiphospholipid syndrome are often a therapeutic dilemma
and challenge. Despite our increasing knowledge of this relatively new disease, many …

Objectives Extra-criteria manifestations of antiphospholipid syndrome (APS) might impact on
prognosis and morbidity of the disease. In this study, we aimed to evaluate a population of …

Background and aims Cardiovascular disease (CVD), including coronary artery disease and
stroke/peripheral artery disease, is less commonly reported than venous thromboembolism …

Objectives aPL are frequently present in SLE. In a well characterized SLE cohort we aimed
at investigating the prevalence of aPL and assessing their analytical performance and …

Background Antiphospholipid syndrome (APS) or 'Hughes syndrome'is a prothrombotic
disease characterized by thrombosis and pregnancy morbidity in the presence of …

Objective: Our aim was to characterize distinctive clinical antiphospholipid syndrome
phenotypes and identify novel microRNA (miRNA)-mRNA-intracellular signaling regulatory …